Vetanco, an international veterinary laboratory that for over 30 years has been developing, manufacturing and marketing innovative products for animal health and production is adding access to its Colombia subsidiary web page, https://www.vetanco.com/co/ , through […] See more

Our specialists participated in the “Conference of Research Workers in Animal Diseases 2020” held virtually last December 5-8. The “Conference of Research Workers in Animal Diseases 2020”, locally known as “CRWAD 2020 Conference” took place […] See more

Using two different platforms, Argentine researchers were able to neutralize the virus. Using “nanobodies” obtained from llamas and with egg immunoglobulins AS A TEAM, BIOINNOVO’S WORKING GROUP JOINING EFFORTS FOR CONTINUOUS GROWTH. There is no […] See more

Bioinnovo, a public-private partnership between INTA and Vetanco S.A., will allocate an important support, granted by the Ministry of Productive Development, to increase the production of Vedevax Block in order to meet local demand and […] See more

Bioinnovo SA was part of a multidisciplinary team responsible for the development of avian IgY antibodies that neutralize the virus causing COVID-19 The project, “Development and production of critical reagents for COVID-19 diagnosis and treatment: […] See more

Algenex, the Spanish company delivering recombinant technologies, a key factor for the development of Vedevax BLOCK, has opened a new production plant for vaccines in the suburbs of Madrid*. The new facility has the capacity […] See more

Specialists of the National Institute of Industrial Technology (INTI) and the national company Ivema Desarrollos designed an essential device for a rapid diagnostic test to substitute imports, reduce costs to the half and meet the […] See more

The Andean Country authorized the commercialization of Vedevax Block, the first recombinant vaccine for the control of the virus. The product developed by Bioinnovo SA, a company created by a partnership between the National Institute […] See more